IPHA
Innate Pharma
IPHA
IPHA
13 hedge funds and large institutions have $3.2M invested in Innate Pharma in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
-3
Holders Change %
-18.75%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
$1.7M |
| 2 |
Jane Street
New York
|
$127K |
| 3 |
Morgan Stanley
New York
|
$151K |
| 4 |
Barclays
London,
United Kingdom
|
$11K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
$3K |
